Cite
Targeted disruption of glycogen synthase kinase-3β in cardiomyocytes attenuates cardiac parasympathetic dysfunction in type 1 diabetic Akita mice.
MLA
Zhang, Yali, et al. “Targeted Disruption of Glycogen Synthase Kinase-3β in Cardiomyocytes Attenuates Cardiac Parasympathetic Dysfunction in Type 1 Diabetic Akita Mice.” PloS One, vol. 14, no. 4, Apr. 2019, p. e0215213. EBSCOhost, https://doi.org/10.1371/journal.pone.0215213.
APA
Zhang, Y., Welzig, C. M., Haburcak, M., Wang, B., Aronovitz, M., Blanton, R. M., Park, H.-J., Force, T., Noujaim, S., & Galper, J. B. (2019). Targeted disruption of glycogen synthase kinase-3β in cardiomyocytes attenuates cardiac parasympathetic dysfunction in type 1 diabetic Akita mice. PloS One, 14(4), e0215213. https://doi.org/10.1371/journal.pone.0215213
Chicago
Zhang, Yali, Charles M Welzig, Marian Haburcak, Bo Wang, Mark Aronovitz, Robert M Blanton, Ho-Jin Park, Thomas Force, Sami Noujaim, and Jonas B Galper. 2019. “Targeted Disruption of Glycogen Synthase Kinase-3β in Cardiomyocytes Attenuates Cardiac Parasympathetic Dysfunction in Type 1 Diabetic Akita Mice.” PloS One 14 (4): e0215213. doi:10.1371/journal.pone.0215213.